Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway

被引:5
作者
Ma, Zelong [1 ]
Zhou, Faxiao [1 ]
Jin, Hua [1 ]
Wu, Xiaoming [1 ]
机构
[1] Kunming Univ Sci & Technol, Med Sch, Lab Mol Genet Aging & Tumor, Chenggong Campus,727 South Jingming Rd, Kunming 650500, Peoples R China
关键词
CXCL12/CXCR4/ACKR3; axis; STAT3 signaling pathway; targeted therapy; JAK2; IL6; EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE MAMMARY CARCINOGENESIS; HUMAN HEPATOCELLULAR-CARCINOMA; CDDO-METHYL ESTER; DOWN-REGULATION; GASTRIC-CANCER; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTORS; ADENOCARCINOMA CELLS; PROTEIN INHIBITOR;
D O I
10.3390/cells13121027
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The reciprocal modulation between the CXCL12/CXCR4/ACKR3 axis and the STAT3 signaling pathway plays a crucial role in the progression of various diseases and neoplasms. Activation of the CXCL12/CXCR4/ACKR3 axis triggers the STAT3 pathway through multiple mechanisms, while the STAT3 pathway also regulates the expression of CXCL12. This review offers a thorough and systematic analysis of the reciprocal regulatory mechanisms between the CXCL12/CXCR4/ACKR3 signaling axis and the STAT3 signaling pathway in the context of diseases, particularly tumors. It explores the potential clinical applications in tumor treatment, highlighting possible therapeutic targets and novel strategies for targeted tumor therapy.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer
    Nazari, Alireza
    Khorramdelazad, Hossein
    Hassanshahi, Gholamhossein
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (06) : 991 - 1000
  • [32] Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer
    Huang, Yu
    Zhang, Jia
    Cui, Zhu-Mei
    Zhao, Jing
    Zheng, Ye
    CHINESE JOURNAL OF CANCER, 2013, 32 (05) : 289 - 296
  • [33] CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
    Guo, F.
    Wang, Y.
    Liu, J.
    Mok, S. C.
    Xue, F.
    Zhang, W.
    ONCOGENE, 2016, 35 (07) : 816 - 826
  • [34] Crosstalk between circular RNAs and the STAT3 signaling pathway in human cancer
    Almouh, Mansour
    Soukkarieh, Chadi
    Kassouha, Morshed
    Ibrahim, Samer
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2024, 1867 (04):
  • [35] Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma
    Rave-Fraenk, Margret
    Tehrany, Narges
    Kitz, Julia
    Leu, Martin
    Weber, Hanne Elisabeth
    Burfeind, Peter
    Schliephake, Henning
    Canis, Martin
    Beissbarth, Tim
    Reichardt, Holger Michael
    Wolff, Hendrik Andreas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (01) : 47 - 54
  • [36] Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients
    Dabrowska, Emilia
    Przylipiak, Andrzej
    Zajkowska, Monika
    Piskor, Barbara M.
    Sidorkiewicz, Iwona
    Szmitkowski, Maciej
    Lawicki, Slawomir
    ANTICANCER RESEARCH, 2020, 40 (06) : 3221 - 3229
  • [37] Can Expression of CXCL12 and CXCR4 Be Used to Predict Survival of Gastric Cancer Patients?
    Satomura, Hitoshi
    Sasaki, Kinro
    Nakajima, Masanobu
    Yamaguchi, Satoru
    Onodera, Shinichi
    Otsuka, Kichiro
    Takahashi, Masakazu
    Muroi, Hiroto
    Shida, Yosuke
    Ogata, Hideo
    Okamoto, Kentaro
    Kato, Hiroyuki
    ANTICANCER RESEARCH, 2014, 34 (08) : 4051 - 4057
  • [38] CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
    Cavallaro, Sebastiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (01) : 1713 - 1727
  • [39] The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
    Wang, Jianhua
    Loberg, Robert
    Taichman, Russell S.
    CANCER AND METASTASIS REVIEWS, 2006, 25 (04) : 573 - 587
  • [40] Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
    Xue, Li-Jun
    Mao, Xiao-Bei
    Ren, Li-Li
    Chu, Xiao-Yuan
    CANCER MEDICINE, 2017, 6 (06): : 1424 - 1436